The Hong Kong Polytechnic University Featured PhD Programmes
University College London Featured PhD Programmes
University of Oxford Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
University of Leeds Featured PhD Programmes
"science" AND "communicat…×
10 miles

Biochemistry (science communication) PhD Projects, Programs & Scholarships

We have 89 Biochemistry (science communication) PhD Projects, Programs & Scholarships

  • "science" AND "communication" ×
  • Biochemistry×
  • clear all
Order by 
Showing 1 to 10 of 89
  The role and regulation of microtubules during axon growth and degeneration
  Prof A Prokop
Applications accepted all year round

Funding Type

PhD Type

Axons are the enormously long cable-like processes of neurons that wire the nervous system. These delicate structures have to be maintained for a life time.
  MRC DiMeN Doctoral Training Partnership: Developing protein tools to target DNA damage response and repair in cancer cells
  Dr Q. Wu, Dr D Tomlinson
Application Deadline: 6 January 2020

Funding Type

PhD Type

DNA damage response (DDR) and repair play critical roles in influencing the efficiency and sensitivity of many cancer treatments.
  MRC DiMeN Doctoral Training Partnership: Killing the unkillable. Developing bacterial capture compounds to identify new targets against antimicrobial resistant Staphylococcus aureus
  Dr R Corrigan, Dr D Williams
Application Deadline: 6 January 2020

Funding Type

PhD Type

The “superbug”, Methicillin resistant Staphylococcus aureus (MRSA) is a major threat to global health. Once inside a host, bacteria, like S.
  MRC DiMeN Doctoral Training Partnership: Killing the unkillable. Developing bacterial capture compounds to identify new targets against antimicrobial resistant Staphylococcus aureus
  Dr R Corrigan, Dr D Williams
Application Deadline: 6 January 2020

Funding Type

PhD Type

The “superbug”, Methicillin resistant Staphylococcus aureus (MRSA) is a major threat to global health. Once inside a host, bacteria, like S.
  MRC DiMeN Doctoral Training Partnership: Combining cutting edge molecular microbiology and super-resolution microscopy to reveal how bacteria divide, and how to stop them
  Dr S Holden, Prof S J Foster
Application Deadline: 6 January 2020

Funding Type

PhD Type

We are looking to recruit an outstanding student to work on uncovering the architecture of the Bacillus subtilis bacterial cell division septum by super-resolution microscopy.
  MRC DiMeN Doctoral Training Partnership: Targeting cancer through disruption of the ubiquitin economy
  Prof M Clague, Prof S Urbé
Application Deadline: 6 January 2020

Funding Type

PhD Type

A PhD project in the shared laboratory of Prof. Michael Clague and Prof. Sylvie Urbé http://pcwww.liv.ac.uk/~clague/ in collaboration with an industry partner.
  MRC DiMeN Doctoral Training Partnership: Use of 3D skin models and patient-derived immune cells to elucidate the molecular mechanisms of skin detachment in severe drug-induced skin adverse reactions
  Dr D Carr, Prof D Naisbitt, Prof A Dickinson
Application Deadline: 6 January 2020

Funding Type

PhD Type

Background. Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening skin adverse drug reactions which can be caused by a multitude of prescriptions drugs.
  MRC DiMeN Doctoral Training Partnership: How do non-coding enhancer RNAs confer genetic risk in Amyotrophic Lateral Sclerosis (ALS)?
  Dr Dan Bose, Dr J Cooper-Knock
Application Deadline: 6 January 2020

Funding Type

PhD Type

Project. Amyotrophic Lateral Sclerosis (ALS) is an aggressive neurodegenerative disease with no effective therapy. The established genetic causes of ALS can only explain a small fraction of the observed disease phenotypes.
  MRC DiMeN Doctoral Training Partnership: How do non-coding enhancer RNAs confer genetic risk in Amyotrophic Lateral Sclerosis (ALS)?
  Dr Dan Bose, Dr J Cooper-Knock
Application Deadline: 6 January 2020

Funding Type

PhD Type

Project. Amyotrophic Lateral Sclerosis (ALS) is an aggressive neurodegenerative disease with no effective therapy. The established genetic causes of ALS can only explain a small fraction of the observed disease phenotypes.
  MRC DiMeN Doctoral Training Partnership: Investigating the in vivo targets and mechanism of action of a toxic acetylcholinesterase-derived peptide upregulated in Alzheimer’s disease
  Dr M Collins, Prof S Greenfield
Application Deadline: 6 January 2020

Funding Type

PhD Type

Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterised by the deposition and accumulation of amyloid beta plaques and phosphorylated tau filaments in the brain, the latter correlating with the onset of symptoms.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.